Crown Castle (CCI) News Today

Crown Castle Inc. (NYSE: CCI) has been getting support from stronger-than-expected second-quarter results, but that optimism is being tempered by several Wall Street price-target cuts.

• Positive Sentiment: Crown Castle beat Q2 expectations on key measures, including FFO and revenue, helped by lower interest expense. The company also updated full-year 2026 outlook, which suggests management sees improved operating momentum and progress from asset sales, debt repayment, and land investments. Crown Castle Reports Second Quarter 2026 Results and Updates Outlook for Full Year 2026
• Positive Sentiment: Analysts remain generally constructive despite trimming targets: Citigroup kept a buy rating, Citizens JMP kept market outperform, TD Cowen kept buy, and RBC kept outperform. Even with lower targets, the firms still see meaningful upside from current levels, signaling that expectations for CCI remain relatively favorable. Analyst price target updates
• Neutral Sentiment: Multiple analysts lowered price targets after the earnings release, including Citigroup to $98 from $106, Citizens JMP to $120 from $125, JPMorgan to $85 from $95, TD Cowen to $92 from $94, and RBC to $90 from $92. The cuts reflect a more cautious valuation stance, but not a bearish shift in ratings overall. Analyst price target updates
• Neutral Sentiment: Other coverage highlighted that Q2 results beat estimates even as site-rental revenue was affected by certain items, suggesting the quarter was solid but still showed some business mix or timing pressure. Crown Castle Q2 earnings beat even as site rental revenue impacted by items
• Negative Sentiment: Despite the earnings beat, the stock remains well below its recent highs, and the repeated target cuts may indicate analysts are resetting expectations for slower growth or a lower valuation multiple going forward. Analyst price target updates

Overall, CCI appears to be rising on the back of a better-than-expected quarter and improved outlook, but the move is being moderated by cautious analyst revisions to valuation targets.